Enzyme-Activating Antibodies Revealed As Marker for Severe Rheumatoid Arthritis

News   May 30, 2013

 
Enzyme-Activating Antibodies Revealed As Marker for Severe Rheumatoid Arthritis
 
 
 

RELATED ARTICLES

British Pharmacological Society’s Drug Discovery of the Year 2018 Announced

News

A new medicine used to treat an ultra-rare inherited disorder which leaves babies without a fully functioning immune system has been named the British Pharmacological Society’s Drug Discovery of the Year 2018.

READ MORE

New Rapid Test for Valley Fever Should Help Reduce Diagnosis Delays

News

November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.

READ MORE

What Does the Future of Vaccines and Immunotherapy Look Like?

News

Innovative biomaterials could enhance vaccines against HIV and other infectious diseases and immunotherapies for patients with cancer or dampen responses in autoimmune disorders, allergies and transplanted organ recipients. A review of these efforts was recently released.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE